Pediatric infectious diseases refer to infections that affect infants, children, and adolescents, caused by bacteria, viruses, fungi, or parasites. Common conditions include respiratory tract infections, gastrointestinal illnesses, meningitis, and vaccine-preventable diseases such as measles and whooping cough. Children are particularly vulnerable due to developing immune systems, making early diagnosis, vaccination, and timely treatment essential. Pediatric infectious disease specialists play a critical role in prevention, management, and improving outcomes through child-focused healthcare strategies.
Market Analysis: In 2025, the global pediatric infectious diseases market—including vaccines, diagnostics, and therapeutics—is valued at around USD 19.3 billion. Rising investments in immunization programs, advanced diagnostic tools, and novel pediatric formulations are expected to drive the market to USD 30.8 billion by 2030, at a CAGR of 9.8%. North America and Europe lead with high vaccine adoption and advanced pediatric care, while Asia-Pacific and Africa are witnessing the fastest growth due to larger child populations, rising infection rates, and expanding public health initiatives.
